Featured Research

from universities, journals, and other organizations

Ovastacin cuts off sperm binding

Date:
April 2, 2012
Source:
Rockefeller University Press
Summary:
A new study describes how a secreted enzyme helps egg cells avoid being fertilized by more than one sperm.

A study in the Journal of Cell Biology describes how ovastacin helps egg cells avoid being fertilized by more than one sperm. In this image, ovastacin (red) localizes to secretory granules (green) in the cortex of an unfertilized egg.
Credit: Burkart, A.D., et al. 2012. J. Cell Biol. http://dx.doi.org/10.1083/jcb.201112094.

Researchers have described how a secreted protease helps egg cells avoid being fertilized by more than one sperm.

Related Articles


Because polyspermy disrupts embryonic development, oocytes take several steps to ensure they only fuse with a single sperm. One key step is to prevent additional sperm from binding to the surface of an already-fertilized egg, a blockade that involves the release of secretory granules and cleavage of the glycoprotein ZP2, a component of the zona pellucida matrix that surrounds eggs. ZP2 is cleaved upstream of two acidic amino acids, a cleavage site recognized by the astacin family of metalloendoproteases. Burkart et al. therefore investigated the function of ovastacin, an astacin family member expressed in oocytes.

Ovastacin localized to cortical granules that were exocytosed after fertilization, and recombinant ovastacin cleaved ZP2 when added to zonae pellucidae. Mice lacking ovastacin failed to cleave ZP2 after fertilization, allowing sperm to continue to bind to the surface of early embryos. Ovastacin-null female mice had slightly fewer offspring than wild-type animals but otherwise appeared normal.

The researchers found that ovastacin targeted several sites in ZP2's N terminus. Senior author Jurrien Dean now wants to investigate how this proteolysis blocks sperm binding, a critical question because the molecular interactions between sperm and egg cells remain unknown. He also wants to examine how ovastacin is packaged into oocyte cortical granules and to identify other components of these secretory organelles.


Story Source:

The above story is based on materials provided by Rockefeller University Press. Note: Materials may be edited for content and length.


Journal Reference:

  1. A. D. Burkart, B. Xiong, B. Baibakov, M. Jimenez-Movilla, J. Dean. Ovastacin, a cortical granule protease, cleaves ZP2 in the zona pellucida to prevent polyspermy. The Journal of Cell Biology, 2012; 197 (1): 37 DOI: 10.1083/jcb.201112094

Cite This Page:

Rockefeller University Press. "Ovastacin cuts off sperm binding." ScienceDaily. ScienceDaily, 2 April 2012. <www.sciencedaily.com/releases/2012/04/120402124335.htm>.
Rockefeller University Press. (2012, April 2). Ovastacin cuts off sperm binding. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2012/04/120402124335.htm
Rockefeller University Press. "Ovastacin cuts off sperm binding." ScienceDaily. www.sciencedaily.com/releases/2012/04/120402124335.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins